Get started
Author

E. Bolli

Observed names: Bolli, Bolli E, Bolli, E., E A Bolli, E Bolli, E. Boli, Ester Bolli
OpenAlex ID: A5002201619
Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil
1993 · Ave Mori, Sergio Bertoglio, et al. · Cancer Chemotherapy and Pharmacology · 50
Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
1995 · A F Sobrero, C Aschele, et al. · PubMed · 31
Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancer
1992 · A. Sobrero, M.T. Nobile, et al. · European Journal of Cancer · 16
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma
1994 · R Rosso, T Mazzei, et al. · European Journal of Cancer · 15
Adjuvant Treatment of Colorectal Cancer in the Elderly.
1995 · Aschele, Guglielmi, et al. · PubMed · 14
Dacarbazine and fotemustine in advanced colorectal cancer
1993 · L. Tixi, E. Bolli, et al. · European Journal of Cancer · 12
5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer
1995 · GLISP (Gruppo Ligure Studio Pancreas), E. Bolli, et al. · Cancer Chemotherapy and Pharmacology · 5
5-Fluorouracil may have different mechanisms of action depending on the dose schedule: clinical implications
1994 · C. Aschele, A. Sobrero, et al. · Cancer Treatment An Update · 1
305 Circumvention of resistance to 5-fluorouracil by schedule-oriented biochemical modulation in advanced colon cancer patients
1995 · A. Sobrero, C. Aschele, et al. · European Journal of Cancer
Standard indication of immunotherapy for the treatnent of cancer
1992 · E. Boli, L. Tina, et al. · Pharmacological Research
Works count: 13
Citation count: 144
H-index: 6
I10-index: 6
Year
Topic
Type